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Abstract
Invariant NKT cells are innate lymphocytes with a broad tissue distribution. Here we demonstrate that iNKT cells reside in
the central nervous system (CNS) in the absence of inflammation. Their presence in the CNS dramatically augments
following inoculation of C57Bl/6 mice with the neurotropic Theiler’s murine encephalomyelitis virus (TMEV). At the peak of
inflammation the cellular infiltrate comprises 45 000 iNKT cells for 1 250 CD8 T cells specific for the immunodominant TMEV
epitope. To study the interaction between these two T cell subsets, we infected both iNKT cell deficient Ja18-/- mice and
iNKT cell enriched Va14 transgenic mice with TMEV. The CD8 T cell response readily cleared TMEV infection in the iNKT cell
deficient mice. However, in the iNKT cell enriched mice TMEV infection persisted and was associated with significant
mortality. This was caused by the inhibition of the CD8 T cell response in the cervical lymph nodes and spleen after T cell
priming. Taken together we demonstrate that iNKT cells reside in the CNS in the absence of inflammation and that their
enrichment is associated with the inhibition of the anti-viral CD8 T cell response and an augmented mortality during acute
encephalomyelitis.
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Introduction
The central nervous system (CNS) is classically considered an
immune privileged environment in which immunogens can persist
in the parenchyma without eliciting an adaptive immune response
[1–3]. Despite this feature the CNS is not deprived from immune
intervention. Resident glial cells constitute a local innate immune
system. Microglia are derived from primitive macrophages and
function in the CNS as immune sentinels that search for microbial
presence by protruding their processes throughout the surround-
ing tissue [4,5]. Focal brain injury attracts microglial processes to
the site of insult within minutes [6,7]. Presence of pathogens or
tissue damage will activate the inflammasome of microglia and/or
astrocytes via the engagement of Toll Like receptors (TLRs) or
nucleotide-binding domain leucine-rich repeat-containing recep-
tors (NLRs) that recognise pathogen-associated molecular patterns
(PAMPs) or damage-associated molecular patterns (DAMPS) [8].
This activation of microglia permits the expression of major
histocompatibility (MHC) class I and II molecules. This allows
microglial cells to present phagocytosed antigen to effector T cells
that can efficiently infiltrate the CNS parenchyma after their
activation in the secondary lymphoid organs [9]. In the absence of
dedicated lymphoid drainage for the CNS the priming of the
adaptive immune response is ensured when CNS-tropic pathogens
passage through peripheral organs prior to ingress of the CNS [8].
Infections of the CNS usually generate efficient inflammatory
responses. This results in the eradication of the infectious agent
with limited tissue damage. Occasionally excessive immune
activity can cause severe CNS pathology [10], or the infectious
agent can escape immune clearance and establish persistence or
latency within the parenchyma [11]. Upon CNS inflammation the
resident cells cooperate with incoming immune cells to ensure
efficient intervention. Activated microglia and probably reactive
astrocytes can express MHC class II enabling the presentation of
antigen to CD4+ T cell responses [12,13]. Furthermore, MHC
class I expression can be induced on all CNS resident cells.
Consequently, cytotoxic CD8+ T cells are able to kill neurons,
oligodendrocytes and astrocytes in an antigen-specific manner that
involves the formation of an immunological synapse between
neural cells and killer T cells [14–17].
The contribution of other T cells to neuroinflammation is less
well characterised. In this study we addressed the role of invariant
NKT (iNKT) cells during CNS viral infection. iNKT cells express
a unique semi-invariant ab T cell receptor (TCR). In humans, this
TCR comprises a Va24-Ja18 rearranged chain combined with a
Vb11 chain, while in mice this TCR comprises a Va14-Ja18 chain
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paired with a restricted set of b-chains [18]. iNKT cells develop in
the thymus where CD1d expressing double-positive thymocytes
trigger their selection and differentiation [19–21]. By virtue of
their semi-variant TCR iNKT cells recognise glycolipids that are
presented in the context of the non-classical MHC molecule CD1d
[22]. The restricted TCR usage by iNKT cells suggests the
recognition of a conserved set of antigens. These include lipids
produced by bacteria or isolated from house dust indicating that
the presence of non-self lipids can mobilise iNKT cells during
microbial infections and possibly asthma [23–28]. The foreign
nature of the lipids is in part reflected by the alpha-anomeric
orientation of the glycosidic linkage between the carbohydrate
headgroup and the lipid backbone, which is not known to be
generated in mammals [29]. During viral infections, autoimmune
inflammation or cancer iNKT cells are also activated, probably in
response to the presentation of endogenous antigens. These
include ligands such as peroxisome-derived lipids [30], Lyso-
phospholipids [31], and in mice isoglobotrihexosyl ceramide
(iGb3) [21]. The presentation of these endogenous ligands can
be induced after activation of the innate immune system by TLR-9
engagement in the presence of type-I interferons [32]. Alterna-
tively, in infected cells, modified self-lipids can be generated by
virus-induced secretory phospholipases and serve as antigens for
the iNKT cell response [33]. Hence, during microbial infections
iNKT cells can be activated by exogenous as well as endogenous
lipid moieties.
The functional contribution of iNKT cells to the immune
response is highly variable. During infections iNKT cells operate
at the interface of innate and adaptive immunity playing a central
role in promoting the acquired immune response [18]. Studies
regarding their role in organ-specific autoimmunity have revealed
an immunosuppressive function for iNKT cells in animal models
of type I diabetes and multiple sclerosis [34]. As such, autoimmune
inflammation of the CNS can be prevented by the activation of
iNKT cells with exogenous glycolipid antigens, or by increasing
the frequency of iNKT cells, as is the case in mice that express a
transgene encoding the invariant TCR alpha chain [35–40]. Less
is known regarding the role of iNKT cells during viral infections of
the CNS. Theiler’s murine encephalomyelitis virus (TMEV) is a
neurotropic picornavirus whose natural host is the mouse. In
experimental conditions, after intracranial inoculation, this virus
not only induces an acute encephalomyelitis in all laboratory
strains of mice but is able to persist indefinitely in the white matter
of susceptible strains [41–43]. In this study we addressed the
function of iNKT cells in the resistant C57BL/6 mice, which clear
TMEV infection after acute encephalomyelitis.
Materials and Methods
Ethics Statement
Animals were housed in the animal facilities of the Pasteur
Institute (accreditation number 75-15-01) or the INSERM
(Zootechnie UMS-006; accreditation number A-31 55508) that
are accredited by the French Ministry of Agriculture to perform
experiments on live mice in appliance of the French and European
regulations on care and protection of the Laboratory Animals (EC
Directive 2010/63, French Law 2013-118, February 6th, 2013).
All protocols using TMEV infection were approved by the
veterinary staff of the Pasteur Institute animal facility which has
been accredited with an NIH Animal Welfare Insurance #A5476-
01 issued on 31/07/2012. Non-infectious experiments were
performed in the INSERM animal facility (Zootechnie UMS-
006) under protocol (04 U563RL-27) and approved by the
facilities veterinary staff and the Midi-Pyre´ne´es ethics committee
(approved by the ministry of higher education and research) in
accordance to the above-mentioned European regulations. Ani-
mals were housed under standard conditions with a 12-hour light/
dark cycle and access to food and water ad libitum. Animal suffering
was reduced by keeping the number of animals used to a
minimum required for the planned studies to give statistically
significant data.
Animals
The Ja18-/- and Va14-Ja18 transgenic (Va14 Tg) non-obese
diabetic (NOD) mice have already been described [44,45]. The
Va14 Tg NOD mice were crossed on a C57Bl/6 background for
over 12 generations to create the Va14 Tg C57Bl/6 mouse line.
These mice were bred and maintained under specific pathogen
free (SPF) conditions and used with sex-matched controls between
4–8 weeks of age.
TMEV, Peptides, and Infection
The Daniels (DA) strain of TMEV, was produced by
transfection of BHK-21 cells with the pTM762 plasmid as
described elsewhere [46,47]. TCR Va14-Ja18 Tg and Ja18-/-
mice on the resistant C57Bl/6 background were anaesthetized
with ether and infected intracerebrally with 104 PFU of TMEV in
40 ml of phosphate-buffer saline.
The H2-Db restricted VP2 derived peptide 122–130
(HAGSLLVFM) was synthesized by Neosystem (Strasbourg,
France) to a purity of .90%.
CNS-infiltrating mononuclear cell purification
Anesthetized mice were perfused through the left cardiac
ventricle with cold PBS. The brain and spinal cord were dissected.
Brain tissue was dissociated by passages over three consecutive
cell-strainers of 150, 100, 40 microns. Single-cell suspensions were
resuspended in 30% percoll and deposited on 70% percoll. After a
20-minute centrifugation at 3000 rpm mononuclear cells were
collected at the interface, washed twice in medium and used for
further analysis.
ELISpot
Peptide-specific T cells were enumerated using an ELISpot
assay as previously described [48]. 96 well plates containing
nitrocellulose filters (Multiscreen; Millipore Corp., Molsheim,
France) were coated overnight with sterile anti-IFN-cmAbs at 4uC
(R4-6A2, BD Biosciences). The plates were washed 3 times with
DMEM and saturated for one hour with complete DMEM. Single
cell splenocytes or Percoll purified mononuclear cells from the
CNS, were cultured at 16106 cells/well and restimulated or not
with the VP2122–130 peptide at 1 or 10 mM (triplicates). After
40 hrs, plates were washed three times with PBS-Tween and PBS,
incubated 2 hrs with biotinylated anti-mouse IFN-c (XMG1.2,
BD Biosciences) and 1.5 hrs with alkaline phosphatase–conjugated
streptavidin (Roche Molecular Biochemicals, Mannheim, Ger-
many). Spots were developed by adding phosphatase substrates, 5-
bromo-4,3-indolyl phosphate, and nitroblue tetrazolium (Promega
Corp., Madison, Wisconsin, USA) and spot forming cells (SFC)
counted using the automated image analysis system KS ELIspot
(Zeiss, Le Pecq, France). A response .10 spots over background
per well was considered specific. Every mononuclear cell sample
was analyzed by flow cytometry to assess the proportion of
CD8+TCRb+ T cells. This proportion was used as denominator
for the frequency of DA-peptide specific CD8 T cells. The
absolute number was calculated based by multiplying the
iNKT Cells Regulate the CD8 T Cell Response
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frequency of SFC with the total number of mononuclear cells
obtained after percoll purification.
RNA isolation
Isolated cells were resuspended in RNAprotect cell reagent and
kept at 280uC until use. RNA was extracted using a RNeasy-plus
mini kit and QiaShredders according to the manufacturer’s
instructions (Qiagen, Courtaboeuf, France). The quality of the
RNA was assessed by capillary electrophoresis (Agilent Bioanaly-
zer, Agilent Technologies) and by spectrometry (l260/l280) prior
to further use. One mg of total RNA was converted into a
representative cDNA pool using the Superscript III First-Strand
Synthesis System and random-hexamer primers, according to the
manufacturer’s instructions (Invitrogen, Cergy Pontoise, France).
QPCR primers and gene-expression analysis
The following published primer pairs were used: CCL5:
forward: 59-GCCCACGTCAAGGAGTATTTCTA-39, reverse:
59-ACACACTTGGCGGTTCCTTC-39; CXCL10: forward 59-
GCCGTCATTTTCTGCCTCAT-39, reverse 59-GCTTCCCT-
ATGGCCCTCATT-39; GATA-3: forward 59-CTTATCAAGC-
CCAAGCGAAG-39, reverse 59- CCCATTAGCGTTCCTCC-
TC-39; Granzyme B: forward 59-CGATCAAGGATCAGCAG-
CCT-39, reverse 59-CTTGCTGGGTCTTCTCCTGTTCT-39;
HPRT: forward 59-TGACACTGGTAAAACAATGCAAACT-
39, reverse 59-AACAAAGTCTGGCCTGTATCCAA-39; IFN-c:
forward 59-TCAAGTGGCATAGATGTGGAAGAA-39, reverse
59-TGGCTCTGCAGGATTTTCATG-39; IL-4: forward 59-
ACAGGAGAAGGGACGCCAT-39, reverse 59-GAAGCCCTA-
CAGACGAGCTCA-39; IL-10: forward 59-GGTTGCCAAGC-
CTTATCGGA-39, reverse 59-CTGTCATCGATTTCTCCC-39;
IL-13: forward 59-GGAGCTGAGCAACATCACACA-39, re-
verse 59-GGTCCTGTAGATGGCATTGCA-39 IL-17: forward
59-CCACGTCACCCTGGAACTCTC-39, reverse 59-CTCCG-
CATTGACACAGCG-39.
Perforin: forward 59-GAAGACCTATCAGGACCAGTACAA-
CTT-39, reverse: 59-CAAGGTGGAGTGGAGGTTTTTG-39;
Rorct: Forward 59- TTCACCCCACCTCCACTG-39, reverse
59-CAAGGGATCACTTCAATTTGTG-39; TNF-a: forward 59-
CATCTTCTCAAAATTCGAGTGACAA-39, reverse 59-CACG-
TCGTAGCAAACCACCAAGTGGA-39; T-bet: forward 59-TC-
AACCAGCACCAGACAGAG-39, reverse 59-AAACATCCTG-
TAATGGCTTGTG-39.
The housekeeping gene HPRT was used as an endogenous
control. Quantitative PCR was performed using the ABI Prism
7000 Sequence Detection System (Applied Biosystems, Foster
City, USA). Each reaction was performed in 25 ml volume in a 96-
well plate (Applied Biosystems) containing 1 ml of cDNA, 12.5 ml
of SYBR Green I Master Mix 2X (Eurogentec, Angers, France),
30 nM of yeast tRNA (Sigma), and 300 nM each of the forward
and reverse primers (Invitrogen). Conditions for the PCR were
2 min at 95uC, and then 40 cycles, each consisting of 15 s at 95uC
and 1 min at 60u–62uC.
The DDCt calculation for the relative transcript quantification
was applied as follows DDCt = (Cttarget gene – CtHPRT)x –
(Cttarget gene – CtHPRT)y, where x = sample to analyze and y
= an arbitrarily chosen control sample. Results for each sample
were expressed as fold changes in target gene copies, according to
the following equation: amount of target transcripts = 2-DDCt.
Two independent experiments were carried out for each gene and
sample. In each experiment, each sample was tested in duplicate
wells.
Viral load determination
Quantification of viral genome was performed by real-time PCR
as described previously [49] using as primers HPRT: Forward
CTGGTGAAAAGGACCTCTCG, Reverse TGAAGTACTCA-
TTATAGTCAAGGGCA and probe Yakima Yellow-TGTTGG-
ATACAGGCCAGACTTTGTTGGAT-DDQ1; TMEV : For-
ward GCCGCTCTTCACACCCAT, Reverse AGCAGGGCA-
GAAAGCATCAC and the probe 6FAM-CGACGTGGTTGGA-
GAT-DDQ1. Viral load is presented as the square root of the
TMEV copy-number over the copy-number of HPRT.
Flow cytometry
After Fcc receptor blockade with the 2.4G2 mAb, cells were
stained with biotinylated CD1d:a-GalCer tetramers labeled with
allophycocyanin, as previously described [50]. Additional stainings
were performed with the following mAbs: anti-b TCR (H57-597),
anti-CD4 (RM4-5), anti-CD8 (53.6.2). Cells were acquired with a
FACSCalibur (Becton Dickinson, Mountain View, CA) and
analyzed using CellQuest or Flowjo software. For cell-sorting,
cells were passed through a FACSAria flow-cytometer (Becton
Dickinson, Mountain View, CA) using FACS-diva software.
Histology
For neuropathology, deeply anesthetized mice were transcar-
dially perfused with 4% paraformaldehyde. Tissues were embed-
ded in paraffin. Immunohistochemistry was performed without
pretreatment as previously described [51], using a Rabbit
Polyclonal serum (1:2500) produced against purified TMEV virus,
with haematoxylin as nuclear counterstain [52]. Labeling was
visualized with 3,3 diaminobenzidine-tetra-hydrochloride (Sigma-
Aldrich).
Statistical Analysis
Statistical significance was determined using the two tailed non-
parametric Mann-Whitney U test and P values below 0.05 were
accepted as significant (*p,0.05; **, p,0.01; ***, p,0.001).
Results
Invariant NKT cells reside in the CNS in the absence of
inflammation
iNKT cells are widely distributed throughout the body. They
express an effector/memory phenotype associated with a chemo-
kine/homing receptor profile affording their presence in non-
lymphoid tissues [53–55]. To test if iNKT cells could reside in the
CNS in the absence of inflammation we assessed the frequency of
CD1d:aGalCer positive iNKT cells among mononuclear cells
purified from uninfected wild-type animals. As shown in figure 1,
the CD1d:aGalCer tetramer provided little or no staining of
mononuclear cells purified from the CNS or liver of TcR Ja18-/-
mice that selectively lack iNKT cells (Fig 1A). By contrast, in
C57Bl/6 wild-type mice iNKT cells represented, on average, 10%
of total T cells isolated from the CNS (Fig 1B). To reduce
contamination by circulating iNKT cells all mice were transcar-
dially perfused with PBS prior to the isolation of CNS
mononuclear cells. Moreover, iNKT cells in the peripheral blood,
taken prior to PBS perfusion, only made up for 0.3% of circulating
T cells. The frequency of iNKT cells in the CNS is therefore,
significantly higher than that detected among T cells in the
peripheral blood (Fig 1B). Taken together, these arguments
strongly suggest that iNKT cells reside in the CNS even in the
absence of inflammation. By multiplying the frequency of iNKT
cells with the total number of mononuclear cells obtained after
iNKT Cells Regulate the CD8 T Cell Response
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percoll purification, we estimated the absolute number of iNKT
cells to amount to an average of 3900 iNKT cells per CNS
(Fig 1C).
Invariant NKT cells infiltrate the CNS after local viral
infection
Following intracerebral inoculation with the DA strain of
TMEV (104 pfu/mouse) the virus initially replicates in neurons
and all mice develop acute grey matter encephalitis. In resistant
mouse strains such as the C57Bl/6, this infection is cleared within
3 weeks by an anti-viral CD8 T cell response peaking 8–10 days
post-inoculation (p.i.). To assess if this adaptive immune response
is accompanied, or even preceded, by the infiltration of iNKT cells
in the CNS we infected C57Bl/6 mice and TCR Va14 transgenic
(Va14 Tg) mice with TMEV and assessed the absolute numbers of
iNKT cells that infiltrated the CNS at different timepoints p.i.. As
shown in figure 2A, iNKT cells were identified among percoll
purified mononuclear cells from the CNS using CD1d:aGalCer
tetramers. In TMEV infected wild-type mice an average of
4.56104 iNKT cells could be detected at the peak of inflammation
(8 days p.i.) representing a 17-fold amplification over basal levels
(Fig 2B). This was accompanied by a massive infiltration of
mononuclear cells to the CNS (Fig 2D) that diluted the overall
frequency of iNKT cells among the inflammatory infiltrate. In the
iNKT cell-enriched Va14 Tg mice the intracerebral infection with
TMEV caused an accumulation of iNKT cells with similar
dynamics. At the peak of inflammation an average of 506104
iNKT cells had accumulated in the CNS, representing a 200-fold
Figure 1. iNKT cells reside in the CNS in the absence of
inflammation. (A) Mononuclear cells were isolated from the brain and
spinal cord (left), spleen (middle), and liver (right) of unmanipulated
adult C57Bl/6 (top) or Ja18-/- C57Bl/6 mice (bottom) by percoll gradient.
A representative CD1d:a-GalCer tetramer staining on mononuclear cells
is presented. (B) Frequency of CD1d:a-GalCer tetramer positive cells
among ab T cells in the liver (n = 6), spleen (n = 7), peripheral blood
(n = 5), CNS (n = 7, 3–16 pooled tissues/observation). (C) Absolute
numbers of CD1d:a-GalCer tetramer positive ab T cells in the liver
(n = 5) and CNS (n = 7, 3–16 pooled tissues/observation) among percoll
purified mononuclear cells. Data represent the mean 6 SEM of n
individual mice per group.
doi:10.1371/journal.pone.0087717.g001
Figure 2. iNKT cells accumulate in the CNS during TMEV
infection. (A) Representative CD1d:a-GalCer tetramer staining on
purified mononuclear cells from the CNS of wild type C57Bl/6 (left) and
TCR Va14 Tg mice (right) 8 days after infection with 104 pfu of TMEV.
(B–C) Absolute number of CD1d:a-GalCer ab T cells (left) and their fold
increase (right) in the CNS after TMEV infection of C57Bl/6 mice (B) and
Va14 Tg mice (C). Absolute number of purified mononuclear cells from
the CNS of C57Bl/6 (D) and Va14 Tg mice (E). Data represent the mean
6 SEM of 2 independent experiments with 2–4 pooled mice/
observation.
doi:10.1371/journal.pone.0087717.g002
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increase over basal levels (Fig 2C). Similar to the wild-type mice,
infection of the Va14 Tg mice caused strong local inflammation
(Fig 2E). These observations indicate that iNKT cells accumulate
locally during CNS viral infection.
CNS viral infection is lethal in mice enriched in iNKT cells
The clinical consequence of neurotropic viral infection was
assessed in Va14 Tg mice, Ja18-/- mice, and C57Bl/6 wild-type
mice over a period of 45 days. As shown in Figure 3A, 8 out of 21
(38%) Va14 Tg mice that are enriched in iNKT cells died. In
contrast, none out of the 19 C57Bl/6 littermates died (LogRank
test p= 0.003). The increased mortality was correlated with a
significantly augmented viral load in the Va14 Tg mice that was
detectable at day 8 (0.4060.09 (n= 19) versus 0.0760.03 (n= 8) in
C57Bl/6; p = 0.04) and persisted until day 45 (0.3660.10 (n= 13)
versus 0.0760.02 (n = 19) in C57Bl/6; p = 0.0002) (Fig 3 B–C).
Histological analysis of infected Va14 Tg mice revealed presence
of TMEV (Fig 4D) with coinciding neuronal degeneration (Fig 4B)
in the hippocampus and cortex 12 days after TMEV infection (2
out of 3 mice analysed). No degeneration or TMEV was detected
in a single wild type mouse at the same time point (Fig 4A and C).
By day 35 post infection, TMEV was no longer detected by
immunohistochemistry in Va14 Tg mice (0 out of 7 mice) or wild-
type mice (0 out of 6 mice), only in H2-Db -/- + H2-Kb -/- that lack
a CD8 T cell compartment could we detect presence of TMEV in
the hippocampus and cortex (4 out of 8 mice, data not shown).
The wild-type and Ja18-/- mice had similar very low viral load in
the CNS at 8 and 45 days post infection (data not shown). These
observations indicated that the enrichment in iNKT cells
permitted a persistent infection of TMEV, which was correlated
with an increased mortality. Given the striking phenotype in the
Va14 Tg mice we focussed our study on the comparison between
TMEV infected Va14 Tg mice and C57Bl/6 mice.
The enrichment in iNKT cells inhibits the anti-viral CD8 T
cell response
In C57Bl/6 mice TMEV infection is fully cleared by an anti-
viral CD8 T cell response that essentially targets the immunodo-
minant, H2-Db restricted epitope VP2122–130 [42]. Inhibition of
this anti-viral CD8 T cell response in the Va14 Tg mice could
contribute to the defect in TMEV elimination. To test this
hypothesis we enumerated TMEV-specific CD8 T cells using an
IFN-c ELIspot assay. Figure 5 reveals the frequency (A) and
absolute number (B) of effector CD8 T cells that responded to
VP2122–130 in the CNS of TMEV infected mice. These data
indicate that a sizeable anti-viral CD8 T cell response infiltrates
the CNS of both C57Bl/6 wild-type mice and Va14 Tg mice.
However, the accumulation of TMEV-specific CD8 T cells is
delayed in the CNS of TMEV infected Va14 Tg mice (peak at day
10) as compared to infected wild-type controls (peak at day 8)
(Fig 5A). In addition, the magnitude of the TMEV-specific CD8 T
cell response is reduced in the CNS of Va14 Tg mice compared to
infected wild-type mice (Fig 5B). At the peak of CD8 T cell
infiltration in the Va14 Tg mice the absolute numbers of TMEV
specific CD8 T cells amounts to 130+/269, which is 9-fold less
than that observed in wild-type mice where the TMEV-specific
CD8 T cell response amounted to 1192+/2207. The blunting of
the CD8 T cell response is likely to originate in the secondary
lymphoid organs. Indeed, the mice enriched in iNKT cells mount
a CD8 T cell response that is indistinguishable from that of
infected wild-type mice 6 days post-infection in the cervical lymph
nodes (Fig 5C) and the spleen (Fig 5D). However, in wild-type
mice the TMEV-specific CD8 T cells response expands until day
Figure 3. Increased mortality and viral load in TCR Va14 Tg
mice infected with TMEV. (A) Kaplan-Meyer survival curve of Va14
Tg C57Bl/6 mice (n = 21) and C57Bl/6 littermates (n = 19) infected with
104 pfu of TMEV. (B) TMEV viral load in the spinal cord 8 days after
infection of Va14 Tg C57Bl/6 mice (n = 13) and C57Bl/6 littermates
(n = 19). (C) TMEV viral load in the spinal cord 45 days after infection of
Va14 Tg C57Bl/6 mice (n = 19) and C57Bl/6 littermates (n = 8). Data
represent the pooled observations of 2–3 independent experiments.
doi:10.1371/journal.pone.0087717.g003
Figure 4. Neuropathology of TMEV infection. (A) In C57Bl/6 mice
NeuN staining demonstrated no degeneration in the hippocampus 12
days post-infection with TMEV. Inset shows a higher magnification of
the CA1 region. (B) In Va14 Tg C57Bl/6 mice NeuN staining revealed
neuronal loss in CA1 and CA2 regions of the hippocampus 12 days
post-infection with TMEV. (C) On consecutive sections, TMEV protein
could not be detected in C57Bl/6 mice, while in the Va14 Tg C57Bl/6
mice (D) TMEV was readily detectable in the hippocampus (arrowhead)
and in the cortex (arrows). Insets show higher magnifications of the CA1
region.
doi:10.1371/journal.pone.0087717.g004
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8–10, while the TMEV-specific CD8 T cell response in the Va14
Tg mice declines from day 6 onwards. These observations indicate
that the increased viral load observed in the CNS of TMEV-
infected Va14 Tg mice correlates with a delayed recruitment of a
numerically reduced antiviral CD8 T cell response to the CNS.
CNS infiltrating iNKT cells express a pro-inflammatory
gene-expression profile
To further understand the relative contribution of iNKT cells to
the observed phenotype we electronically isolated a-GalCer:CD1d
tetramers positive iNKT cells from the CNS and spleen of the
Va14 Tg mice, using a previously described protocol [56], 8 days
post infection with TMEV. This timepoint corresponds to the
peak of iNKT cell infiltration in the CNS of Va14 Tg mice
(Fig 2C). CD8 T cells were isolated in parallel. Organs from at
least 4 mice were pooled, in each of the 2 experiments gene
expression of a number of nuclear factors and signature cytokines
was analysed by real-time qPCR. The gene-expression profile of
CNS-infiltrating iNKT cells differs from that of splenic iNKT cells
(Fig 6A). Relative to its splenic counterparts CNS iNKT cells
revealed a strongly increased expression of granzyme B, and
CXCL10 and reduced transcription of il4 and il13. This cytokine
profile is consistent with a proinflammatory role of iNKT cells in
the CNS during viral infection. When assessing the gene-
Figure 5. Delayed and blunted VP2122–130 specific CD8 T cell response in TMEV-infected TCR Va14 Tg mice. (A) Frequency and (B–D)
absolute number of the VP2122–130 specific CD8 T cells in the CNS and secondary lymphoid organs of Va14 Tg C57Bl/6 mice and C57Bl/6 littermates
prior to (day 0) or 3, 6, 8, 10, or 13 days after infection with 104 pfu of TMEV. The magnitude of the TMEV-specific CD8 T cell response was determined
by ex vivo IFN-c ELISpot. To this end, mononuclear cells were restimulated or not with 10 mM of the H2-Db-restricted VP2122–130 epitope and IFN-c
spot-forming cells (SFC) were enumerated. (A–B) Representation of the VP2122–130 specific CD8 T cell response among percoll purified mononuclear
cells of the CNS. Each individual timepoint represents 2 independent experiments on pooled mononuclear cells purified from 3–4 mice/group. Data
represent the mean 6 SEM. (C–D) Representation of the VP2122–130 specific CD8 T cell response in the cervical lymph nodes (C) and spleen (D). Data
represents two individual experiments in which the organs of 6–8 mice/group and per timepoint were analysed individually. Data represent the
mean of n individual mice 6 SEM.
doi:10.1371/journal.pone.0087717.g005
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expression of the nuclear factors T-bet, GATA3, and Rorct we
observed that tbet and gata3 expression was comparable but the
intensity of rorct message had increased among CNS infiltrating
iNKT cells. The CD8 T cells, notably in the CNS, expressed an
anticipated inflammatory and cytotoxic profile associated with the
expression of granzyme B, IFNc, perforin, CXCL10, and tbet (Fig 6B).
Strong IL-10 message was equally detected among CD8 T cells,
which is known to tune the effector CD8 T cell response to avoid
excessive tissue damage [15,57]. These data indicate that after
TMEV infection the phenotype of iNKT cells differs drastically
between the spleen and the CNS. In the spleen, where a blunting
of the CD8 T cell response is observed, the iNKT cells express a
phenotype with pronounced expression of il4 and il13. In the CNS
the infiltrating iNKT cells express higher levels of pro-inflamma-
tory or even cytotoxic genes, implying a pro-inflammatory
phenotype of iNKT cells locally at the site of viral infection.
Treatment with exogenous iNKT cell ligands inhibits the
TMEV-specific CD8 T cell response
We next assessed whether the activation of iNKT cells in wild-
type C57Bl/6 mice would influence the magnitude of the TMEV-
specific CD8 T cell response upon infection. To this end C57Bl/6
mice were injected i.p. on the day of TMEV infection with 4 mg of
a-galactosylceramide (a-GalCer) or OCH, an analogue with a
truncated sphingosine chain. Injection of the iNKT cell agonists
reduced the frequency and absolute numbers of TMEV-specific
CD8 T cells in the spleen compared to vehicle treated mice
(Fig 7A). This demonstrates that the activation of iNKT cells by a-
GalCer or OCH can restrain the mounting CD8 T cell response.
This inhibition of the peripheral immune response impacted on
the magnitude of the CD8 T cell response in the CNS (Fig 7B). In
the a-GalCer treated mice a less pronounced accumulation of
CD8 T cells was observed in the CNS both in terms of frequency
and absolute numbers. In OCH treated mice the impact on the
TMEV-specific CD8 T cell response in the CNS was less
pronounced as compared to vehicle treated mice (Fig 7B). No
mortality was observed, and no variation in TMEV transcripts
could be detected in a-GalCer, OCH, or vehicle injected mice
(data not shown). These data indicate that the activation of iNKT
cells using exogenous glycolipid antigens can restrain the
magnitude of the TMEV-specific CD8 T cell response in WT
resistant C57Bl/6 mice without significantly affecting the course of
the infection.
Discussion
In the CNS microglial cells and reactive astrocytes express
CD1d in inflammatory lesions indicating their capacity to present
antigen to iNKT cells [58]. In addition, the CNS is rich in lipids
and glycolipids that include self-antigens for iNKT cells [59].
Infection of the CNS with the neurotropic TMEV provokes
immune intervention including the local accumulation of iNKT
cells. In resistant C57Bl/6 mice the accumulation of iNKT cells
peaks 8 days after infection. This coincides with the peak of the
virus-specific CD8 T cell response in the CNS, which is sufficient
to clear infection in resistant H2-Db strain. At this timepoint in the
CNS the CD8 T cell response targeting the immunodominant
VP2122–130 epitope mounted to 1 250 cells, as assessed by IFNc
Elispot. At the same time on average 45 000 iNKT cells were
found within the same infiltrate underscoring the efficiency of
iNKT cells to accumulate in the CNS during viral infection. The
detection of iNKT cells in the CNS prior to inflammation is likely
to contribute to this increased efficacy. We could establish that
iNKT cells represent 10% of CNS-resident T cells amounting to 4
000 iNKT cells per mouse CNS. This is a small, but significant
number given their highly biased TCR repertoire with common
antigen specificity. Two arguments strongly imply that this was not
due to blood contamination. First, all mice were transcardially
perfused prior to the dissection of the CNS. Second, when
comparing the frequency of iNKT cells among circulating T cells
to those isolated from the CNS a significantly increased proportion
of iNKT was observed in the CNS. These observations strongly
argue that in the absence of inflammation, iNKT cells contribute
to the surveillance of different organs and tissues, including those
that benefit from immune privilege. Due to their low abundance in
the CNS and the technical difficulties associated with the use of
Figure 6. iNKT cells and CD8 T cells in the CNS of TMEV-
infected mice express a cytotoxic phenotype. CD1d:a-GalCer
tetramer+ TCRb+ iNKT cells (A) and TCRb+ CD8+CD42 (B) T cells were
FACS purified from the CNS of Va14 Tg mice 8 days after TMEV
infection. Real-time PCR analysis was performed on mRNA from purified
iNKT cells and CD8 T cells from the spleen (white bars) and CNS (black
bars). Cells were purified (black bars) from CNS-infiltrating mononuclear
cells of 6–8 pooled Va14 Tg mice or (white bars) from individual
spleens. Data represent the mean 6 SD of 2 individual experiments
(CNS) or the mean of 4 individual mice 6 SD (spleen).
doi:10.1371/journal.pone.0087717.g006
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tetramers for immunohistological analyses we could not determine
the exact location of the iNKT cells within the CNS. In man, the
CSF contains only few immune cells (1–5/ ml). These cells are
mainly central memory CD4+ T cells implying that memory T
cells can extravasate from the blood into the CSF, even in the
absence of inflammation [60,61]. As iNKT cells are innate
memory cells expressing a broad chemokine/homing receptor
profile for non-lymphoid tissues this could, similarly, permit their
migration across the blood-CSF barriers [53–55]. This is further
emphasised by the expression of CCR6, a homing receptor
permitting the entry into the CNS via the choroid plexus [62],
which can be detected on human CD8+ and CD42CD82 iNKT
cells [53].
In the Va14 Tg mice that are enriched in iNKT cells 38% of
mice developed a fatal acute encephalomyelitis, which was
associated with a failure to clear TMEV infection. This was
associated with a marked blunting of the anti-viral CD8 T cell
response. This resulted in a delay in the recruitment of the anti-
viral CD8 T cell response to the CNS of Va14 Tg mice (peak at
day 10) when compared to wild-type mice (peak day 8). In
addition, the magnitude of the CNS infiltrating VP2122–130-specific
CD8 T cell response was reduced by 5-fold in the Va14 Tg mice
compared to the wild-type mice. This deficit originated in the
secondary lymphoid organs. Intriguingly, the priming of the anti-
viral CD8 T cell response remained unaltered between the Va14
Tg mice and the TMEV infected wild-type controls. However,
from day 6 onwards the VP2122–130-specific CD8 T cell response
was strongly blunted in the Va14 Tg mice. We did not address the
underlying mechanisms directly. However, we have previously
used the Va14 Tg mice to study the impact of iNKT cells on
experimental autoimmune encephalomyelitis (EAE). In this model,
the MOG35–55-specific CD4
+ T cell response was regulated after
egress from the draining lymph nodes. Using this model we could
exclude deficits in the T cell repertoire [56], exclude a role for IL-4
[38], and exclude the requirement for CD1d to impose iNKT cell
immune regulation [56]. Collectively, these data indicate that, in
the Va14 Tg mice, iNKT cells can actively regulate an anti-viral
CD8 T cell response via as yet unidentified mechanisms.
Two non-mutually exclusive mechanisms are likely to explain
the mortality observed in the TMEV-infected Va14 Tg mice. One
mechanism would argue that the absence of a TMEV-specific
CD8 T cell response permits uninhibited viral dissemination.
Virus driven tissue damage would then prove fatal over time. This
scenario is supported by the persistence of TMEV over time, the
blunted CD8 T cell response in the CNS and the fact that both the
CD8-deficient H2-Db-/- and b2-microglobulin-/- mice that fail to
clear TMEV infection succumb to a fatal outcome in a similar
percentage of mice [63–66]. However, a few arguments are
available to suspect a more complex mechanism. First, the CD8 T
cell response is inhibited but not absent from the Va14 Tg mice.
Furthermore, the TMEV viral load in the Va14 Tg mice at late
stages is inferior to that seen in the H2-Db-/- mice [63,64]. This
indicates that the Va14 Tg mice still partly control TMEV
infection. In this case the mortality is unlikely to be solely due to
viral mediated tissue damage. This is consistent with the use of the
less aggressive DA strain of TMEV which differs from the GDVII
strain by a more moderate neurolytic activity [41]. A second
scenario would imply that the mortality of the Va14 Tg mice is
potentially driven by an excessive encephalitogenic immune
response. This response is relatively poor in anti-viral CD8 T
cells but rich in iNKT cells (4.5 105 iNKT cells at day 8 p.i.). The
suggestion that this iNKT cell response could contribute to neural
damage is supported by our quantitative PCR experiments on
electronically purified iNKT cells from the CNS of TMEV-
infected Va14 Tg mice. These purified CNS iNKT cells expressed
little IL-4, IL-10 and IL-13 transcripts, but are strong producers of
Granzyme B and CXCL-10, indicative of a pro-inflammatory
cytotoxic function. In concordance with this scenario, when we
infected H2-Db -/- + H2-Kb -/- (n = 21) and compared them to
infected H2-Db -/- + H2-Kb -/- + b2-microglobulin-/- (n = 16) we
observed an increased mortality (14% vs 69%; p= 0.002) and viral
load at 45 days p.i. (0.3+/20.1 (n = 16) vs 1.4+/20.4 (n = 5)
TMEV/HPRT) among surviving H2-Db -/- + H2-Kb -/- + b2-
Figure 7. Activation of iNKT cells inhibits the VP2122–130-specific CD8 T cell response in TMEV infected C57Bl/6 mice. Frequency (left)
and absolute number (right) of the VP2122–130-specific CD8 T cells in the spleen (A) and CNS (B) of C57Bl/6 mice 8 or 9 days after infection with
104 pfu of TMEV. On the day of infection mice received a single injection of 4 mg of a-GalCer, OCH, or vehicle i.p. The magnitude of the TMEV-specific
CD8 T cell response was determined by ex vivo IFN-c ELISpot. To this end, mononuclear cells were restimulated or not with 10 mM of the H2-Db-
restricted VP2122–130 epitope and IFN-c spot-forming cells (SFC) were enumerated. (A) Data represents two individual experiments in which the
organs of 4 mice/group were analysed individually. The mean of 8 individual mice6 SEM is presented. (B) Represents 2 independent experiments on
pooled mononuclear cells purified from the CNS of 4 mice/group. Data represent the mean 6 SEM.
doi:10.1371/journal.pone.0087717.g007
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microglobulin-/- mice. This underlines that non-classical MHC I
molecules, which are absent in mice deficient for b2-microglobu-
lin, are non-redundant for the protection against CNS viral
infections. Similarly, an immuno-pathological event during the
acute encephalomyelitis probably explains the difference of
mortality of B10.S mice bearing different Il22 variants after
intracerebral TMEV inoculation [49].
Taken together, our observations indicate that iNKT cells are
present in the CNS even in the absence of inflammation. The
magnitude of CNS iNKT cells dramatically increases after local
virus infection. This implies that iNKT cells may play an
important role in the immune surveillance in the CNS. In
addition we demonstrated that the enrichment of iNKT cells
regulates the CD8 T cell response after virus infection. The fact
that this could be reproduced by injecting a-GalCer or OCH
might raise some caution for strategies that aim to improve
vaccination efficacy with iNKT cell ligands.
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